| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 140, 769-774, Copyright © 1992 by American Society for Investigative Pathology
REGULAR ARTICLES |
D Shibata and LM Weiss
Department of Pathology, Los Angeles County, University of Southern California Medical Center 90033.
The Epstein-Barr virus (EBV) has been detected in certain types of lymphoma and some epithelial neoplasms including nasopharyngeal lymphoepithelioma, and rare lymphoepithelioma-like carcinomas occurring in a variety of organs including, most recently, the stomach. The authors investigated the possibility that EBV may be present not only in the rare gastric cancers that resemble nasopharyngeal lymphoepithelioma, but also in typical gastric adenocarcinoma. EBV sequences were detected in 22 of 138 (16%) cases of typical gastric adenocarcinoma by polymerase chain reaction and in situ hybridization (ISH) techniques. The EBV genomes were specifically present within the gastric carcinoma cells in an even distribution. The EBV genomes were also present in adjacent dysplastic epithelium but were absent in surrounding lymphocytes, other normal stromal cells, intestinal metaplasia, and normal gastric mucosa. The EBV genomes in the infected gastric carcinoma cells are expressed as EBV RNA was detected by ISH. EBV was most often detected in gastric tumors from men (21%) compared with women (3%). Thus some cases of gastric adenocarcinoma are EBV- associated.
This article has been cited by other articles:
 |
|
 |
|
  H-J Delecluse, R Feederle, B O'Sullivan, and P Taniere Epstein Barr virus-associated tumours: an update for the attention of the working pathologist J. Clin. Pathol., December 1, 2007; 60(12): 1358 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-L. Tsai, H.-P. Li, Y.-J. Lu, C. Hsueh, Y. Liang, C.-L. Chen, S. W. Tsao, K.-P. Tse, J.-S. Yu, and Y.-S. Chang Activation of DNA Methyltransferase 1 by EBV LMP1 Involves c-Jun NH2-Terminal Kinase Signaling Cancer Res., December 15, 2006; 66(24): 11668 - 11676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Minoura-Etoh, K. Gotoh, R. Sato, M. Ogata, N. Kaku, T. Fujioka, and A. Nishizono Helicobacter pylori-associated oxidant monochloramine induces reactivation of Epstein-Barr virus (EBV) in gastric epithelial cells latently infected with EBV. J. Med. Microbiol., July 1, 2006; 55(Pt 7): 905 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Gao, H. Wang, and T. Sairenji Inhibition of Epstein-Barr Virus (EBV) Reactivation by Short Interfering RNAs Targeting p38 Mitogen-Activated Protein Kinase or c-myc in EBV-Positive Epithelial Cells J. Virol., November 1, 2004; 78(21): 11798 - 11806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Huang, J. S-H Tsung, C.-W. Lin, and T.-Y. Cheng Intrahepatic Cholangiocarcinoma with Lymphoepithelioma-Like Carcinoma Component Ann. Clin. Lab. Sci., October 1, 2004; 34(4): 476 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. El-Guindy and G. Miller Phosphorylation of Epstein-Barr Virus ZEBRA Protein at Its Casein Kinase 2 Sites Mediates Its Ability To Repress Activation of a Viral Lytic Cycle Late Gene by Rta J. Virol., July 15, 2004; 78(14): 7634 - 7644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A zur Hausen, B P van Rees, J van Beek, M E Craanen, E Bloemena, G J A Offerhaus, C J L M Meijer, and A J C van den Brule Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis J. Clin. Pathol., May 1, 2004; 57(5): 487 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Kutok, S. Klumpp, M. Simon, J. J. MacKey, V. Nguyen, J. M. Middeldorp, J. C. Aster, and F. Wang Molecular Evidence for Rhesus Lymphocryptovirus Infection of Epithelial Cells in Immunosuppressed Rhesus Macaques J. Virol., April 1, 2004; 78(7): 3455 - 3461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Lee, M. S. Chang, H.-K. Yang, B. L. Lee, and W. H. Kim Epstein-Barr Virus-Positive Gastric Carcinoma Has a Distinct Protein Expression Profile in Comparison with Epstein-Barr Virus-Negative Carcinoma Clin. Cancer Res., March 1, 2004; 10(5): 1698 - 1705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fukuda and R. Longnecker Latent Membrane Protein 2A Inhibits Transforming Growth Factor-{beta}1-Induced Apoptosis through the Phosphatidylinositol 3-Kinase/Akt Pathway J. Virol., February 15, 2004; 78(4): 1697 - 1705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. van Beek, A. zur Hausen, E. Klein Kranenbarg, C. J.H. van de Velde, J. M. Middeldorp, A. J.C. van den Brule, C. J.L.M. Meijer, and E. Bloemena EBV-Positive Gastric Adenocarcinomas: A Distinct Clinicopathologic Entity With a Low Frequency of Lymph Node Involvement J. Clin. Oncol., February 15, 2004; 22(4): 664 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Etoh, Y. Kanai, S. Ushijima, T. Nakagawa, Y. Nakanishi, M. Sasako, S. Kitano, and S. Hirohashi Increased DNA Methyltransferase 1 (DNMT1) Protein Expression Correlates Significantly with Poorer Tumor Differentiation and Frequent DNA Hypermethylation of Multiple CpG Islands in Gastric Cancers Am. J. Pathol., February 1, 2004; 164(2): 689 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Thompson and R. Kurzrock Epstein-Barr Virus and Cancer Clin. Cancer Res., February 1, 2004; 10(3): 803 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Iwakiri, Y. Eizuru, M. Tokunaga, and K. Takada Autocrine Growth of Epstein-Barr Virus-Positive Gastric Carcinoma Cells Mediated by an Epstein-Barr Virus-Encoded Small RNA Cancer Res., November 1, 2003; 63(21): 7062 - 7067. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Chen, S. Y. Leung, S. T. Yuen, K.-M. Chu, J. Ji, R. Li, A. S.Y. Chan, S. Law, O. G. Troyanskaya, J. Wong, et al. Variation in Gene Expression Patterns in Human Gastric Cancers Mol. Biol. Cell, August 1, 2003; 14(8): 3208 - 3215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Wakisaka, S. Murono, T. Yoshizaki, M. Furukawa, and J. S. Pagano Epstein-Barr Virus Latent Membrane Protein 1 Induces and Causes Release of Fibroblast Growth Factor-2 Cancer Res., November 1, 2002; 62(21): 6337 - 6344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-h. Feng, E. Westphal, A. Mauser, N. Raab-Traub, M. L. Gulley, P. Busson, and S. C. Kenney Use of Adenovirus Vectors Expressing Epstein-Barr Virus (EBV) Immediate-Early Protein BZLF1 or BRLF1 To Treat EBV-Positive Tumors J. Virol., October 2, 2002; 76(21): 10951 - 10959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. van Rees, E. Caspers, A. zur Hausen, A. van den Brule, P. Drillenburg, M. A. J. Weterman, and G. J. A. Offerhaus Different Pattern of Allelic Loss in Epstein-Barr Virus-Positive Gastric Cancer with Emphasis on the p53 Tumor Suppressor Pathway Am. J. Pathol., October 1, 2002; 161(4): 1207 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q N Vo, J Geradts, M L Gulley, D A Boudreau, J C Bravo, and B G Schneider Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation J. Clin. Pathol., September 1, 2002; 55(9): 669 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-N. Tsai, C.-L. Tsai, K.-P. Tse, H.-Y. Chang, and Y.-S. Chang The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases PNAS, July 23, 2002; 99(15): 10084 - 10089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-h. Feng, B. Israel, N. Raab-Traub, P. Busson, and S. C. Kenney Chemotherapy Induces Lytic EBV Replication and Confers Ganciclovir Susceptibility to EBV-positive Epithelial Cell Tumors Cancer Res., March 1, 2002; 62(6): 1920 - 1926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Maruo, L. Yang, and K. Takada Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells J. Gen. Virol., October 1, 2001; 82(10): 2373 - 2383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Chu, Y.-Y. Chen, W.-g. Chen, and L. M. Weiss No Direct Role for Epstein-Barr Virus in American Hepatocellular Carcinoma Am. J. Pathol., October 1, 2001; 159(4): 1287 - 1292. [Abstract] [Full Text]
|
|
|
|
|
|
P. G. Chu, K. L. Chang, Y.-Y. Chen, W.-G. Chen, and L. M. Weiss No Significant Association of Epstein-Barr Virus Infection with Invasive Breast Carcinoma Am. J. Pathol., August 1, 2001; 159(2): 571 - 578. [Abstract] [Full Text]
|
|
|
|
|
|
Y. M. D. Lo, W. Y. Chan, E. K. W. Ng, L. Y. S. Chan, P. B. S. Lai, J. S. Tam, and S. C. S. Chung Circulating Epstein-Barr Virus DNA in the Serum of Patients with Gastric Carcinoma Clin. Cancer Res., July 1, 2001; 7(7): 1856 - 1859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Trivedi, P. Spinsanti, L. Cuomo, M. Volpe, K. Takada, L. Frati, and A. Faggioni Differential Regulation of Epstein-Barr Virus (EBV) Latent Gene Expression in Burkitt Lymphoma Cells Infected with a Recombinant EBV Strain J. Virol., May 15, 2001; 75(10): 4929 - 4935. [Abstract] [Full Text]
|
|
|
|
 |
|
 A A T P Brink, C J L M Meijer, J M Nicholls, J M Middeldorp, and A J C van den Brule Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders Mol. Pathol., April 1, 2001; 54(2): 98 - 102. [Abstract] [Full Text]
|
|
|
|
|
|
A. Janz, M. Oezel, C. Kurzeder, J. Mautner, D. Pich, M. Kost, W. Hammerschmidt, and H.-J. Delecluse Infectious Epstein-Barr Virus Lacking Major Glycoprotein BLLF1 (gp350/220) Demonstrates the Existence of Additional Viral Ligands J. Virol., November 1, 2000; 74(21): 10142 - 10152. [Abstract] [Full Text]
|
|
|
|
|
|
P G Murray and L S Young Themed issue: the biology and pathology of the Epstein-Barr virus Mol. Pathol., October 1, 2000; 53(5): 219 - 221. [Full Text]
|
|
|
|
|
|
K Takada Epstein-Barr virus and gastric carcinoma Mol. Pathol., October 1, 2000; 53(5): 255 - 261. [Abstract] [Full Text]
|
|
|
|
|
|
E. M. Westphal, W. Blackstock, W. Feng, B. Israel, and S. C. Kenney Activation of Lytic Epstein-Barr Virus (EBV) Infection by Radiation and Sodium Butyrate in Vitro and in Vivo: A Potential Method for Treating EBV-positive Malignancies Cancer Res., October 1, 2000; 60(20): 5781 - 5788. [Abstract] [Full Text]
|
|
|
|
|
|
A. z. Hausen, A. A. T. P. Brink, M. E. Craanen, J. M. Middeldorp, C. J. L. M. Meijer, and A. J. C. van den Brule Unique Transcription Pattern of Epstein-Barr Virus (EBV) in EBV-carrying Gastric Adenocarcinomas: Expression of the Transforming BARF1 Gene Cancer Res., May 1, 2000; 60(10): 2745 - 2748. [Abstract] [Full Text]
|
|
|
|
|
|
R. F. Ambinder Gammaherpesviruses and ""Hit-and-Run"" Oncogenesis Am. J. Pathol., January 1, 2000; 156(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Franchini, R. F. Ambinder, and M. Barry Viral Disease in Hematology Hematology, January 1, 2000; 2000(1): 409 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T.K.-H. Stadtlander and J. W. waterbor Molecular epidemiology, pathogenesis and prevention of gastric cancer Carcinogenesis, December 1, 1999; 20(12): 2195 - 2208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.-M. Westphal, A. Mauser, J. Swenson, M. G. Davis, C. L. Talarico, and S. C. Kenney Induction of Lytic Epstein-Barr Virus (EBV) Infection in EBV-associated Malignancies Using Adenovirus Vectors in Vitro and in Vivo Cancer Res., April 1, 1999; 59(7): 1485 - 1491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Nishikawa, S. Imai, T. Oda, T. Kojima, K. Okita, and K. Takada Epstein-Barr Virus Promotes Epithelial Cell Growth in the Absence of EBNA2 and LMP1 Expression J. Virol., February 1, 1999; 73(2): 1286 - 1292. [Abstract] [Full Text]
|
|
|
|
|
|
C. W. Dawson, J. Dawson, R. Jones, K. Ward, and L. S. Young Functional Differences between BHRF1, the Epstein-Barr Virus-Encoded Bcl-2 Homologue, and Bcl-2 in Human Epithelial Cells J. Virol., November 1, 1998; 72(11): 9016 - 9024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Komano, M. Sugiura, and K. Takada Epstein-Barr Virus Contributes to the Malignant Phenotype and to Apoptosis Resistance in Burkitt's Lymphoma Cell Line Akata J. Virol., November 1, 1998; 72(11): 9150 - 9156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Iwasaki, J.-M. Chong, Y. Hayashi, R. Ikeno, K. Arai, M. Kitamura, M. Koike, K. Hirai, and M. Fukayama Establishment and Characterization of a Human Epstein-Barr Virus-Associated Gastric Carcinoma in SCID Mice J. Virol., October 1, 1998; 72(10): 8321 - 8326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Imai, J. Nishikawa, and K. Takada Cell-to-Cell Contact as an Efficient Mode of Epstein-Barr Virus Infection of Diverse Human Epithelial Cells J. Virol., May 1, 1998; 72(5): 4371 - 4378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Clark, Yoke Sun Lee, K.-W. Min, and S. T. Dunn Epstein-Barr Virus in Gastric Carcinomas from Singapore International Journal of Surgical Pathology, January 1, 1996; 4(3): 149 - 158. [Abstract] [PDF]
|
|
|
|
|
|
J. K. C. Chan, T. T. C. Yip, W. Y. W. Tsang, S. Seneviratne, Y.F. Poon, C. S. C. Wong, and V. W. S. Ma Lack of Evidence of Pathogenetic Role of Epstein-Barr Virus in Thymic Lymphoid Hyperplasia and Thymomas in the Chinese Population of Hong Kong International Journal of Surgical Pathology, July 1, 1994; 2(1): 17 - 22. [Abstract] [PDF]
|
|
|
|
|
|
S. Murono, H. Inoue, T. Tanabe, I. Joab, T. Yoshizaki, M. Furukawa, and J. S. Pagano Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells PNAS, June 5, 2001; 98(12): 6905 - 6910. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
